Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

837
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
837

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

Future oncology (London, England)·2026
Same author

Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma.

JTO clinical and research reports·2026
Same author

Risk Factors in Sporadic Early-Onset Colorectal Cancer, Current Evidence and Emerging Insights: A Systematic Review.

Cancers·2026
Same author

A Systematic Review and Meta-Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid Tumours.

Cancer medicine·2026
Same author

A multicomponent, place-based approach to improving men's health and well-being in disadvantaged areas: a qualitative study.

Journal of public health (Oxford, England)·2026
Same author

Genomic Therapy Matching in Rare and Refractory Cancers.

JAMA oncology·2026

Related Experiment Video

Updated: Mar 29, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.9K

Optimal therapy for resectable rectal cancer.

Subotheni Thavaneswaran1, Timothy J Price2

  • 1a NHMRC Clinical Trials Centre , Chris O'Brien Lifehouse , Camperdown NSW , Australia.

Expert Review of Anticancer Therapy
|December 15, 2015
PubMed
Summary
This summary is machine-generated.

Optimizing rectal cancer treatment involves balancing recurrence risk with therapy toxicity. This review explores a shift towards earlier, intense systemic treatments and reduced local therapies for better outcomes and quality of life.

Keywords:
Locally advancedresectable rectal cancer

More Related Videos

The Pocket-Creation Procedure of Endoscopic Submucosal Dissection for Large Rectal Laterally Spreading Tumors
04:09

The Pocket-Creation Procedure of Endoscopic Submucosal Dissection for Large Rectal Laterally Spreading Tumors

Published on: February 13, 2026

97
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

2.0K

Related Experiment Videos

Last Updated: Mar 29, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.9K
The Pocket-Creation Procedure of Endoscopic Submucosal Dissection for Large Rectal Laterally Spreading Tumors
04:09

The Pocket-Creation Procedure of Endoscopic Submucosal Dissection for Large Rectal Laterally Spreading Tumors

Published on: February 13, 2026

97
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

2.0K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Rectal cancer treatment requires balancing recurrence risks with therapy-related toxicities.
  • Tumor location significantly impacts treatment morbidity.
  • Optimal sequencing of therapies is crucial for patient outcomes.

Purpose of the Study:

  • To review the shift towards earlier, more intense systemic treatments in rectal cancer.
  • To evaluate the evidence supporting reduced local therapies.
  • To assess the impact of these changes on local control, distal disease, treatment morbidity, and quality of life.

Main Methods:

  • Literature review of recent studies and clinical trials.
  • Analysis of treatment strategies focusing on systemic versus local therapies.
  • Evaluation of data on recurrence rates, toxicity profiles, and patient-reported outcomes.

Main Results:

  • Emerging evidence suggests a trend towards intensified systemic neoadjuvant therapies.
  • Reduced local treatment intensity may be feasible with effective systemic approaches.
  • Balancing oncologic control with treatment-related morbidity remains a key challenge.

Conclusions:

  • The shift towards earlier, intense systemic therapy in rectal cancer warrants further investigation.
  • Future trials are needed to confirm the safety and efficacy of reduced local therapies.
  • Optimizing treatment sequencing is essential for improving long-term outcomes and quality of life in rectal cancer patients.